Inhibiting apoptosis with adenovirus RID protein

   
   

A method for inhibiting apoptosis of a cell expressing a death receptor of the TNFR family is disclosed. The method involves treating the cell with a Receptor Internalization and Degradation (RID) protein complex containing RID.alpha. (10.4K) and RID.beta. (14.5K) proteins encoded by the E3 region of adenovirus. The cell can be treated by administering to the cell a polynucleotide expressing the RID complex or by administering to the cell a composition containing the RID complex. Compositions containing a RID complex are also disclosed. The compositions and method are useful in the treatment of cancer, degenerative and immune disorders, as well as in promoting survival of tissue transplants. An adenovirus vector for delivering the RID complex to cells is also disclosed.

Показан метод для блокировать apoptosis клетки выражая приемное устройство смерти семьи TNFR. Метод включает обработать клетку с комплекс протеином приемного устройства Internalization и (RID) ухудшения содержа RID.alpha. (10.4K) и RID.beta. протеины (14.5K) зашифрованные зоной E3 аденовируса. Клетка может быть обработана путем administering к клетке polynucleotide выражая RID комплекс или путем administering к клетке состав содержа RID комплекс. Составы содержа RID комплекс также показаны. Составы и метод полезны в обработке разладов рака, вырожденческих и иммунных, так же, как в повышать выживание трансплантатов ткани. Вектор аденовируса для поставлять RID комплекс к клеткам также показан.

 
Web www.patentalert.com

< Methods of treatment of immune system related disorders using Neutrokine-alpha

< Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and TACE inhibitors

> Method of stimulating an immune response by administration of host organisms that express intimin alone or as a fusion protein with one or more other antigens

> Nucleic acid sequences that can be used as primers and probes in the amplification and detection of all subtypes of HIV-1

~ 00174